Table 2.
Patient characteristics
| Median age | 49 / (21–63) |
| Female | 3 (21%) |
| Male | 11 (79%) |
| IDH-1/2 wild-type | 12/14 (86%) |
| Unmethylated MGMT promoter | 10/14 (71%) |
| Response | |
| Complete response (CR) | 6 (43%) |
| Partial response (PR) | 6 (43%) |
| Stable disease (SD) | 0 (0%) |
| Progressive disease (PD) | 2 (14%) |